Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A de Jonge

Showing results (51-60 of 286) with videos related to

Pageof 29
Sort By:
Sexual & Reproductive Healthcare : Official Journal of the Swedish Association of Midwives|May 20, 2023
Midwifery care is evidence-based but under increasing pressureR D Maimburg, E R Declercq, A de Jonge
Chemotherapy|August 11, 2025
Therapeutic drug monitoring - a driver to precision medicine for patients with hematological malignanciesJannik Stemler, Roger M Brüggemann, Nick A de Jonge
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1983
Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. III. Comparison of central and peripheral alpha-1 and alpha-2 adrenoceptorsA de Jonge, P B Timmermans, P A van Zwieten
British Journal of Pharmacology|March 1, 1983
Hypotensive and alpha-adrenergic activities of 2-(2,3,6-trichlorophenylimino) and 2-(2,3-dichloro-6-methylphenylimino) imidazolidine, two potent derivatives of clonidineA de Jonge, P B Timmermans, P A van Zwieten
European Journal of Nuclear Medicine|January 1, 1991
Scintigraphy in the clinical evaluation of disorders of mineral and skeletal metabolism in renal failureF A de Jonge, E K Pauwels, N A Hamdy
Journal of Paediatrics and Child Health|December 1, 1991
An analysis of trends in the incidence of sudden infant death in The Netherlands 1969-89A C Engelberts, G A de Jonge, P J Kostense
British Journal of Pharmacology|February 1, 1990
Cyclic GMP release and vasodilatation induced by EDRF and atrial natriuretic factor in the isolated perfused kidney of the ratG A Burton, S MacNeil, A de Jonge, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1982
Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. I. Central hypotensive and peripheral hypertensive activitiesA de Jonge, P B Timmermans, P A van Zwieten
Pharmaceutisch Weekblad. Scientific Edition|October 21, 1983
Inhibitors of the angiotensin I converting enzyme as antihypertensive drugsP A Van Zwieten, A De Jonge, P B Timmermans
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1982
Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. II. Central and peripheral bradycardic activitiesA de Jonge, P B Timmermans, P A van Zwieten
Pageof 29

Showing results (51-60 of 286) with videos related to

Sort By:
Pageof 29
Sexual & Reproductive Healthcare : Official Journal of the Swedish Association of Midwives|May 20, 2023
Midwifery care is evidence-based but under increasing pressureR D Maimburg, E R Declercq, A de Jonge
Chemotherapy|August 11, 2025
Therapeutic drug monitoring - a driver to precision medicine for patients with hematological malignanciesJannik Stemler, Roger M Brüggemann, Nick A de Jonge
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1983
Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. III. Comparison of central and peripheral alpha-1 and alpha-2 adrenoceptorsA de Jonge, P B Timmermans, P A van Zwieten
British Journal of Pharmacology|March 1, 1983
Hypotensive and alpha-adrenergic activities of 2-(2,3,6-trichlorophenylimino) and 2-(2,3-dichloro-6-methylphenylimino) imidazolidine, two potent derivatives of clonidineA de Jonge, P B Timmermans, P A van Zwieten
European Journal of Nuclear Medicine|January 1, 1991
Scintigraphy in the clinical evaluation of disorders of mineral and skeletal metabolism in renal failureF A de Jonge, E K Pauwels, N A Hamdy
Journal of Paediatrics and Child Health|December 1, 1991
An analysis of trends in the incidence of sudden infant death in The Netherlands 1969-89A C Engelberts, G A de Jonge, P J Kostense
British Journal of Pharmacology|February 1, 1990
Cyclic GMP release and vasodilatation induced by EDRF and atrial natriuretic factor in the isolated perfused kidney of the ratG A Burton, S MacNeil, A de Jonge, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1982
Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. I. Central hypotensive and peripheral hypertensive activitiesA de Jonge, P B Timmermans, P A van Zwieten
Pharmaceutisch Weekblad. Scientific Edition|October 21, 1983
Inhibitors of the angiotensin I converting enzyme as antihypertensive drugsP A Van Zwieten, A De Jonge, P B Timmermans
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1982
Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. II. Central and peripheral bradycardic activitiesA de Jonge, P B Timmermans, P A van Zwieten
Pageof 29